Response to 'What rheumatologist should know about Fabry disease' by Moiseev <i>et al</i>.

Vordenbäumen, Stefan; Brinks, Ralph; Richter, Jutta G; Albrecht, Katinka; Schneider, Matthias

Response to 'What rheumatologist should know about Fabry disease' by Moiseev et al.

Vordenbäumen, Stefan; Brinks, Ralph; Richter, Jutta G; Albrecht, Katinka; Schneider, Matthias.

Afiliação

Vordenbäumen S; Rheumatology and Hiller Research Unit, Heinrich-Heine-University Düsseldorf, Medical Faculty, Düsseldorf, Germany stefan.vordenbaeumen@med.uni-duesseldorf.de.
Brinks R; Rheumatology and Hiller Research Unit, Heinrich-Heine-University Düsseldorf, Medical Faculty, Düsseldorf, Germany.
Richter JG; Rheumatology and Hiller Research Unit, Heinrich-Heine-University Düsseldorf, Medical Faculty, Düsseldorf, Germany.
Albrecht K; DRFZ, Berlin, Germany.
Schneider M; Rheumatology and Hiller Research Unit, Heinrich-Heine-University Düsseldorf, Medical Faculty, Düsseldorf, Germany.

Ann Rheum Dis ; 79(6): e72, 2020 06.

Article em En | MEDLINE | ID: mdl-31040121

Assuntos

Artrite Reumatoide; Doença de Fabry; Estudos de Coortes; Humanos; Reumatologistas; alfa-Galactosidase

Palavras-chave

disease activity; inflammation; rheumatoid arthritis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Artrite Reumatoide / Doença de Fabry Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google